Global Debut of the Innovative Paste-Type & Portable Two-in-One Insulin Pump at CMEF!
2023-10-29 09:24
The 88th China International Medical Equipment Fair (CMEF) officially kicked off at the Shenzhen International Convention and Exhibition Center on October 28th, 2023, where AARUY Medical presented its full range of blood glucose management solutions.
CMEF is the largest medical equipment exhibition in Asia. Today, more than 4,000 exhibitors from over 150 countries and regions worldwide have gathered in Shenzhen to explore and discuss the latest developments and trends in the medical field.


Live Report
At this conference, AARUY Medical showcased its insulin pumps, insulin pump infusion management systems, continuous glucose monitoring systems (CGM), artificial pancreas closed-loop management systems, and other flagship products and solutions, attracting enthusiastic attention from industry professionals.


Detailed Introduction of Star Products
Diabetes is the third leading cause of harm to human health and has become a public health issue awaiting resolution across society. "Healthy China Action (2019-2030)" lists "Diabetes Prevention and Control Action" as one of the 15 special actions, specifying the standardized management goals for diabetic patients from 2022 to 2030.
Insulin pump therapy is currently the most effective and least side-effect method for treating diabetes. Insulin pumps on the market are mainly divided into two forms: portable and paste-type. Traditional portable insulin pumps are more economical but inconvenient due to tangled tubing, while paste-type insulin pumps are more discreet and convenient. Currently, the mainstream paste-type insulin pumps on the market include Roche from Europe, Insulet from the United States, Eoflow from South Korea, and even the world's largest medical device giant, Medtronic from the United States, acquired South Korean paste-type insulin pump company Eoflow for $5.2 billion in May this year to fill its gap in the paste-type insulin pump field.
However, all paste-type insulin pumps currently on the market have the indwelling needle located at one end of the pump. The indwelling needle can undergo significant deflection with body movement, leading to large wounds and susceptibility to infection. Additionally, to make the insulin pump more compact, developers of these insulin pumps have designed the reservoirs as 2mL, preventing one-time medicine loading (insulin on the market is packaged in 3mL vials), resulting in medical waste, inconvenient medicine loading, and the risk of medicine liquid contamination.
After in-depth research, AARUY Medical has developed the AR-B200 series insulin pump—the world's first paste-type & portable two-in-one insulin pump. This series of insulin pumps features the following unique functions:
- World's first paste-type & portable two-in-one insulin pump
- World's smallest portable insulin pump
- Patented design balanced indwelling needle solves the industry problem of large wounds and susceptibility to infection caused by paste-type insulin pumps
- Patented design soft indwelling needle solves the problem of foreign body sensation caused by steel needles
- 3mL large reservoir for paste-type pump makes one-time medicine liquid loading more convenient and safer
- Various controllers are available for users to choose from
Once the AARUY Medical AR-B200 series insulin pump was introduced, it attracted widespread attention. With its unique innovative technology, it has gained high recognition from industry experts.
In the future, AARUY Medical will focus on the field of blood glucose management, relying on its strong development capabilities to further improve the blood glucose management product system, comprehensively cover in-hospital and out-of-hospital blood glucose monitoring and control, realize artificial pancreas closed-loop management systems, support the construction of smart hospitals, provide more and better products and services for the vast number of diabetes patients and medical staff, and continuously advance towards the goal of becoming a leading medical device supplier!
Next Page
More news